O	O	0	8	Retinoic	Retinoic	B-NP	JJ	O	2	NMOD	O
O	O	9	13	acid	acid	I-NP	NN	O	3	SUB	O
O	O	14	27	downmodulates	downmodulate	B-VP	VBZ	O	0	ROOT	O
O	O	28	37	erythroid	erythroid	B-NP	JJ	O	5	NMOD	O
O	O	38	53	differentiation	differentiation	I-NP	NN	O	8	NMOD	O
O	O	54	57	and	and	O	CC	O	8	NMOD	O
T1	B-Protein	58	63	GATA1	GATA1	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	64	74	expression	expression	I-NP	NN	O	3	OBJ	O
O	O	75	77	in	in	B-PP	IN	O	8	NMOD	O
O	O	78	86	purified	purify	B-NP	VBN	B-cell_line	14	NMOD	B-cell_line
O	O	87	92	adult	adult	I-NP	JJ	I-cell_line	14	NMOD	I-cell_line
O	O	92	93	-	-	I-NP	HYPH	I-cell_line	14	NMOD	I-cell_line
O	O	93	103	progenitor	progenitor	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	104	111	culture	culture	I-NP	NN	I-cell_line	9	PMOD	I-cell_line
O	O	111	112	.	.	O	.	O	3	P	O

O	O	114	117	All	All	B-NP	DT	O	5	NMOD	O
O	O	117	118	-	-	I-NP	HYPH	O	5	NMOD	O
O	O	118	123	trans	trans	I-NP	NN	O	5	NMOD	O
O	O	124	132	retinoic	retinoic	I-NP	JJ	O	5	NMOD	O
O	O	133	137	acid	acid	I-NP	NN	O	9	SUB	O
O	O	138	139	(	(	O	(	O	8	DEP	O
O	O	139	141	RA	RA	B-NP	NN	O	8	DEP	O
O	O	141	142	)	)	O	)	O	5	NMOD	O
O	O	143	145	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	146	148	an	an	B-NP	DT	O	12	NMOD	O
O	O	149	158	important	important	I-NP	JJ	O	12	NMOD	O
O	O	159	168	morphogen	morphogen	I-NP	NN	O	19	NMOD	O
O	O	169	171	in	in	B-PP	IN	O	12	NMOD	O
O	O	172	182	vertebrate	vertebrate	B-NP	NN	O	15	NMOD	O
O	O	183	194	development	development	I-NP	NN	O	13	PMOD	O
O	O	194	195	,	,	O	,	O	19	P	O
O	O	196	197	a	a	B-NP	DT	O	19	NMOD	O
O	O	198	204	normal	normal	I-NP	JJ	O	19	NMOD	O
O	O	205	216	constituent	constituent	I-NP	NN	O	9	PRD	O
O	O	217	219	in	in	B-PP	IN	O	19	NMOD	O
O	O	220	225	human	human	B-NP	JJ	O	23	NMOD	O
O	O	226	231	adult	adult	I-NP	JJ	O	23	NMOD	O
O	O	232	237	blood	blood	I-NP	NN	O	20	PMOD	O
O	O	238	241	and	and	O	CC	O	9	VMOD	O
O	O	242	244	is	be	B-VP	VBZ	O	9	VMOD	O
O	O	245	249	also	also	I-VP	RB	O	25	VMOD	O
O	O	250	258	involved	involve	I-VP	VBN	O	25	VC	O
O	O	259	261	in	in	B-PP	IN	O	27	VMOD	O
O	O	262	265	the	the	B-NP	DT	O	30	NMOD	O
O	O	266	273	control	control	I-NP	NN	O	28	PMOD	O
O	O	274	276	of	of	B-PP	IN	O	30	NMOD	O
O	O	277	281	cell	cell	B-NP	NN	O	31	PMOD	O
O	O	282	288	growth	growth	B-NP	NN	O	35	NMOD	O
O	O	289	292	and	and	O	CC	O	35	NMOD	O
O	O	293	308	differentiation	differentiation	B-NP	NN	O	32	NMOD	O
O	O	309	311	in	in	B-PP	IN	O	30	NMOD	O
O	O	312	317	acute	acute	B-NP	JJ	O	39	NMOD	O
O	O	318	331	promyelocytic	promyelocytic	I-NP	JJ	O	39	NMOD	O
O	O	332	340	leukemia	leukemia	I-NP	NN	O	36	PMOD	O
O	O	340	341	.	.	O	.	O	9	P	O

O	O	342	344	We	We	B-NP	PRP	O	2	SUB	O
O	O	345	349	have	have	B-VP	VBP	O	0	ROOT	O
O	O	350	358	examined	examine	I-VP	VBN	O	2	VC	O
O	O	359	362	the	the	B-NP	DT	O	5	NMOD	O
O	O	363	370	effects	effect	I-NP	NNS	O	3	OBJ	O
O	O	371	373	of	of	B-PP	IN	O	5	NMOD	O
O	O	374	376	RA	RA	B-NP	NN	O	6	PMOD	O
O	O	377	379	on	on	B-PP	IN	O	5	NMOD	O
O	O	380	386	normal	normal	B-NP	JJ	O	10	NMOD	O
O	O	387	400	hematopoiesis	hematopoiesis	I-NP	NN	O	8	PMOD	O
O	O	401	403	by	by	B-PP	IN	O	3	VMOD	O
O	O	404	409	using	use	B-VP	VBG	O	11	PMOD	O
O	O	410	415	early	early	B-NP	JJ	O	12	OBJ	O
O	O	416	429	hematopoietic	hematopoietic	I-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	430	440	progenitor	progenitor	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	441	446	cells	cell	I-NP	NNS	I-cell_type	13	NMOD	I-cell_type
O	O	447	448	(	(	O	(	O	19	DEP	O
O	O	448	451	HPC	HPC	B-NP	NN	B-cell_type	19	DEP	B-cell_type
O	O	451	452	)	)	O	)	O	16	NMOD	O
O	O	453	464	stringently	stringently	B-VP	RB	O	21	VMOD	O
O	O	465	473	purified	purify	I-VP	VBN	O	13	NMOD	O
O	O	474	478	from	from	B-PP	IN	O	21	VMOD	O
O	O	479	484	adult	adult	B-NP	JJ	O	25	NMOD	O
O	O	485	495	peripheral	peripheral	I-NP	JJ	O	25	NMOD	O
O	O	496	501	blood	blood	I-NP	NN	O	22	PMOD	O
O	O	501	502	.	.	O	.	O	2	P	O

O	O	503	505	In	In	B-PP	IN	O	68	VMOD	O
O	O	506	518	clonogenetic	clonogenetic	B-NP	JJ	B-cell_line	19	NMOD	B-cell_line
O	O	519	524	fetal	fetal	I-NP	JJ	I-cell_line	5	NMOD	I-cell_line
O	O	525	529	calf	calf	I-NP	NN	I-cell_line	5	NMOD	I-cell_line
O	O	530	535	serum	serum	I-NP	NN	I-cell_line	19	NMOD	I-cell_line
O	O	535	536	-	-	B-VP	HYPH	I-cell_line	19	NMOD	I-cell_line
O	O	536	548	supplemented	supplement	I-VP	VBN	I-cell_line	19	NMOD	I-cell_line
O	O	549	550	(	(	O	(	I-cell_line	11	DEP	I-cell_line
O	O	550	553	FCS	FCS	B-NP	NN	I-cell_line	11	DEP	I-cell_line
O	O	553	554	+	+	B-ADJP	SYM	I-cell_line	11	DEP	I-cell_line
O	O	554	555	)	)	O	)	I-cell_line	7	VMOD	I-cell_line
O	O	556	558	or	or	O	CC	I-cell_line	7	VMOD	I-cell_line
O	O	559	560	-	-	O	HYPH	I-cell_line	19	NMOD	I-cell_line
O	O	560	575	nonsupplemented	nonsupplemented	O	JJ	I-cell_line	19	NMOD	I-cell_line
O	O	576	577	(	(	O	(	I-cell_line	19	NMOD	I-cell_line
O	O	577	580	FCS	FCS	O	NN	I-cell_line	19	NMOD	I-cell_line
O	O	580	581	-	-	O	HYPH	I-cell_line	19	NMOD	I-cell_line
O	O	581	582	)	)	O	)	I-cell_line	19	NMOD	I-cell_line
O	O	583	590	culture	culture	B-NP	NN	I-cell_line	1	PMOD	I-cell_line
O	O	591	598	treated	treat	B-VP	VBN	O	19	NMOD	O
O	O	599	603	with	with	B-PP	IN	O	20	VMOD	O
O	O	604	614	saturating	saturating	B-NP	JJ	O	23	NMOD	O
O	O	615	621	levels	level	I-NP	NNS	O	21	PMOD	O
O	O	622	624	of	of	B-PP	IN	O	23	NMOD	O
T2	B-Protein	625	636	interleukin	interleukin	B-NP	NN	B-protein	39	NMOD	B-protein
T2	I-Protein	636	637	-	-	B-NP	HYPH	O	25	P	O
T2	I-Protein	637	638	3	3	I-NP	CD	O	25	NMOD	O
O	O	639	640	(	(	O	(	O	32	DEP	O
T3	B-Protein	640	642	IL	IL	B-NP	NN	B-protein	30	NMOD	B-protein
T3	I-Protein	642	643	-	-	B-NP	HYPH	I-protein	32	DEP	I-protein
T3	I-Protein	643	644	3	3	I-NP	CD	I-protein	30	NMOD	I-protein
O	O	644	645	)	)	O	)	O	25	NMOD	O
T4	B-Protein	646	657	granulocyte	granulocyte	B-NP	NN	B-protein	39	NMOD	B-protein
T4	I-Protein	657	658	-	-	O	HYPH	I-protein	39	NMOD	I-protein
T4	I-Protein	658	668	macrophage	macrophage	B-NP	NN	I-protein	39	NMOD	I-protein
T4	I-Protein	669	675	colony	colony	I-NP	NN	I-protein	39	NMOD	I-protein
T4	I-Protein	675	676	-	-	O	HYPH	I-protein	39	NMOD	I-protein
T4	I-Protein	676	687	stimulating	stimulate	B-VP	VBG	I-protein	39	NMOD	I-protein
T4	I-Protein	688	694	factor	factor	B-NP	NN	I-protein	46	NMOD	I-protein
O	O	695	696	(	(	O	(	O	44	DEP	O
T5	B-Protein	696	698	GM	GM	B-NP	NN	B-protein	43	NMOD	B-protein
T5	I-Protein	698	699	-	-	B-NP	HYPH	I-protein	43	P	I-protein
T5	I-Protein	699	702	CSF	CSF	I-NP	NN	I-protein	44	DEP	I-protein
O	O	702	703	)	)	O	)	O	39	NMOD	O
O	O	704	707	and	and	O	CC	O	46	NMOD	O
T6	B-Protein	708	722	erythropoietin	erythropoietin	B-NP	NN	B-protein	67	NMOD	B-protein
O	O	723	724	(	(	O	(	O	49	DEP	O
T7	B-Protein	724	726	Ep	Ep	B-NP	NN	B-protein	49	DEP	B-protein
O	O	726	727	)	)	O	)	O	46	NMOD	O
O	O	728	729	(	(	O	(	O	46	NMOD	O
O	O	729	737	combined	combine	B-VP	VBN	O	46	NMOD	O
O	O	738	742	with	with	B-PP	IN	O	51	PMOD	O
T8	B-Protein	743	744	c	c	B-NP	NN	O	56	NMOD	O
T8	I-Protein	744	745	-	-	I-NP	HYPH	O	56	NMOD	O
T8	I-Protein	745	748	kit	kit	I-NP	NN	O	56	NMOD	O
T8	I-Protein	749	755	ligand	ligand	I-NP	NN	O	52	PMOD	O
O	O	756	758	in	in	B-PP	IN	O	56	NMOD	O
O	O	759	762	FCS	FCS	B-NP	NN	O	64	NMOD	O
O	O	762	763	(	(	O	(	O	61	DEP	O
O	O	763	764	-	-	B-NP	SYM	O	61	DEP	O
O	O	764	765	)	)	O	)	O	58	NMOD	O
O	O	765	766	-	-	B-NP	HYPH	O	64	P	O
O	O	766	773	culture	culture	I-NP	NN	O	64	NMOD	O
O	O	774	784	conditions	condition	I-NP	NNS	O	57	PMOD	O
O	O	784	785	)	)	O	)	O	46	NMOD	O
O	O	785	786	,	,	O	,	O	67	P	O
O	O	787	789	RA	RA	B-NP	NN	O	24	PMOD	O
O	O	790	797	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	798	799	a	a	B-NP	DT	O	71	NMOD	O
O	O	800	808	dramatic	dramatic	I-NP	JJ	O	71	NMOD	O
O	O	809	813	dose	dose	I-NP	NN	O	74	NMOD	O
O	O	813	814	-	-	B-NP	HYPH	O	74	NMOD	O
O	O	814	823	dependent	dependent	I-NP	JJ	O	74	NMOD	O
O	O	824	829	shift	shift	I-NP	NN	O	80	NMOD	O
O	O	830	834	from	from	B-PP	IN	O	80	NMOD	O
O	O	835	844	erythroid	erythroid	B-ADJP	JJ	O	75	PMOD	O
O	O	845	847	to	to	B-PP	TO	O	80	NMOD	O
O	O	848	864	granulomonocytic	granulomonocytic	B-NP	JJ	O	77	PMOD	O
O	O	865	871	colony	colony	I-NP	NN	O	80	NMOD	O
O	O	872	881	formation	formation	I-NP	NN	O	84	NMOD	O
O	O	881	882	,	,	O	,	O	84	P	O
O	O	883	886	the	the	B-NP	DT	O	84	NMOD	O
O	O	887	893	latter	latter	I-NP	JJ	O	84	NMOD	O
O	O	894	902	colonies	colony	I-NP	NNS	O	85	SUB	O
O	O	903	908	being	be	B-VP	VBG	O	68	VMOD	O
O	O	909	920	essentially	essentially	I-VP	RB	O	87	VMOD	O
O	O	921	932	represented	represent	I-VP	VBN	O	85	VC	O
O	O	933	935	by	by	B-PP	IN	O	87	VMOD	O
O	O	936	948	granulocytic	granulocytic	B-NP	JJ	B-cell_line	90	NMOD	B-cell_line
O	O	949	955	clones	clone	I-NP	NNS	I-cell_line	88	PMOD	I-cell_line
O	O	955	956	.	.	O	.	O	68	P	O

O	O	957	961	This	This	B-NP	DT	O	2	NMOD	O
O	O	962	967	shift	shift	I-NP	NN	O	3	SUB	O
O	O	968	970	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	971	981	apparently	apparently	I-VP	RB	O	3	VMOD	O
O	O	982	985	not	not	I-VP	RB	O	3	VMOD	O
O	O	986	992	caused	cause	I-VP	VBN	O	3	VC	O
O	O	993	995	by	by	B-PP	IN	O	6	VMOD	O
O	O	996	997	a	a	B-NP	DT	O	10	NMOD	O
O	O	998	1009	recruitment	recruitment	I-NP	NN	O	10	NMOD	O
O	O	1010	1020	phenomenon	phenomenon	I-NP	NN	O	7	PMOD	O
O	O	1020	1021	,	,	O	,	O	6	P	O
O	O	1022	1029	because	because	B-SBAR	IN	O	6	VMOD	O
O	O	1030	1032	in	in	B-PP	IN	O	23	VMOD	O
O	O	1033	1036	FCS	FCS	B-NP	NN	B-cell_line	16	NMOD	B-cell_line
O	O	1036	1037	+	+	B-NP	SYM	I-cell_line	16	NMOD	I-cell_line
O	O	1038	1045	culture	culture	I-NP	NN	I-cell_line	13	PMOD	I-cell_line
O	O	1045	1046	,	,	O	,	O	23	P	O
O	O	1047	1050	the	the	B-NP	DT	O	20	NMOD	O
O	O	1051	1056	total	total	I-NP	JJ	O	20	NMOD	O
O	O	1057	1063	number	number	I-NP	NN	O	23	SUB	O
O	O	1064	1066	of	of	B-PP	IN	O	20	NMOD	O
O	O	1067	1075	colonies	colony	B-NP	NNS	O	21	PMOD	O
O	O	1076	1078	is	be	B-VP	VBZ	O	12	SBAR	O
O	O	1079	1082	not	not	I-VP	RB	O	23	VMOD	O
O	O	1083	1096	significantly	significantly	I-VP	RB	O	23	VMOD	O
O	O	1097	1105	modified	modify	I-VP	VBN	O	23	VC	O
O	O	1106	1108	by	by	B-PP	IN	O	26	VMOD	O
O	O	1109	1111	RA	RA	B-NP	NN	O	29	NMOD	O
O	O	1112	1120	addition	addition	I-NP	NN	O	27	PMOD	O
O	O	1120	1121	.	.	O	.	O	3	P	O

O	O	1122	1124	In	In	B-PP	IN	O	27	VMOD	O
O	O	1125	1128	FCS	FCS	B-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	1128	1129	-	-	B-NP	HYPH	I-cell_line	7	NMOD	I-cell_line
O	O	1130	1136	liquid	liquid	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	1136	1137	-	-	B-NP	HYPH	I-cell_line	7	NMOD	I-cell_line
O	O	1137	1147	suspension	suspension	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	1148	1155	culture	culture	I-NP	NN	I-cell_line	1	PMOD	I-cell_line
O	O	1156	1168	supplemented	supplement	B-VP	VBN	O	7	NMOD	O
O	O	1169	1173	with	with	B-PP	IN	O	8	VMOD	O
O	O	1174	1184	saturating	saturate	B-NP	VBG	O	12	NMOD	O
T9	B-Protein	1185	1187	Ep	Ep	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	1188	1193	level	level	I-NP	NN	O	23	NMOD	O
O	O	1194	1197	and	and	O	CC	O	23	NMOD	O
O	O	1198	1201	low	low	B-NP	JJ	O	23	NMOD	O
O	O	1201	1202	-	-	I-NP	HYPH	O	23	NMOD	O
O	O	1202	1206	dose	dose	I-NP	NN	O	23	NMOD	O
T10	B-Protein	1207	1209	IL	IL	I-NP	NN	B-protein	23	NMOD	B-protein
T10	I-Protein	1209	1210	-	-	B-NP	HYPH	I-protein	19	P	I-protein
T10	I-Protein	1210	1211	3	3	I-NP	CD	I-protein	23	NMOD	I-protein
O	O	1211	1212	/	/	I-NP	SYM	O	23	NMOD	O
T11	B-Protein	1212	1214	GM	GM	I-NP	NN	B-protein	23	NMOD	B-protein
T11	I-Protein	1214	1215	-	-	I-NP	HYPH	I-protein	23	NMOD	I-protein
T11	I-Protein	1215	1218	CSF	CSF	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	1218	1219	,	,	O	,	O	26	P	O
O	O	1220	1225	adult	adult	B-NP	JJ	O	26	NMOD	O
O	O	1226	1229	HPC	HPC	I-NP	NN	B-cell_type	9	PMOD	B-cell_type
O	O	1230	1237	undergo	undergo	B-VP	VBP	O	41	VMOD	O
O	O	1238	1248	unilineage	unilineage	B-NP	JJ	O	30	NMOD	O
O	O	1249	1263	erythropoietic	erythropoietic	I-NP	JJ	O	30	NMOD	O
O	O	1264	1279	differentiation	differentiation	I-NP	NN	O	27	OBJ	O
O	O	1279	1280	:	:	O	:	O	27	P	O
O	O	1281	1285	Here	Here	B-ADVP	RB	O	41	VMOD	O
O	O	1286	1291	again	again	B-ADVP	RB	O	41	VMOD	O
O	O	1291	1292	,	,	O	,	O	41	P	O
O	O	1293	1302	treatment	treatment	B-NP	NN	O	41	SUB	O
O	O	1303	1307	with	with	B-PP	IN	O	35	NMOD	O
O	O	1308	1312	high	high	B-NP	JJ	O	40	NMOD	O
O	O	1312	1313	-	-	I-NP	HYPH	O	40	NMOD	O
O	O	1313	1317	dose	dose	I-NP	NN	O	40	NMOD	O
O	O	1318	1320	RA	RA	I-NP	NN	O	36	PMOD	O
O	O	1321	1328	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	1329	1330	a	a	B-NP	DT	O	43	NMOD	O
O	O	1331	1336	shift	shift	I-NP	NN	O	41	OBJ	O
O	O	1337	1341	from	from	B-PP	IN	O	43	NMOD	O
O	O	1342	1345	the	the	B-NP	DT	O	50	NMOD	O
O	O	1346	1355	erythroid	erythroid	I-NP	JJ	O	48	AMOD	O
O	O	1356	1358	to	to	B-PP	TO	O	48	AMOD	O
O	O	1359	1371	granulocytic	granulocytic	B-NP	JJ	O	50	NMOD	O
O	O	1372	1387	differentiation	differentiation	I-NP	NN	O	50	NMOD	O
O	O	1388	1395	pathway	pathway	I-NP	NN	O	44	PMOD	O
O	O	1395	1396	.	.	O	.	O	41	P	O

O	O	1397	1404	Studies	Study	B-NP	NNS	O	15	SUB	O
O	O	1405	1407	on	on	B-PP	IN	O	1	NMOD	O
O	O	1408	1410	RA	RA	B-NP	NN	O	4	NMOD	O
O	O	1411	1415	time	time	I-NP	NN	O	9	NMOD	O
O	O	1415	1416	-	-	B-NP	HYPH	O	9	NMOD	O
O	O	1416	1424	response	response	I-NP	NN	O	9	NMOD	O
O	O	1425	1427	or	or	I-NP	CC	O	9	NMOD	O
O	O	1428	1433	pulse	pulse	I-NP	NN	O	9	NMOD	O
O	O	1434	1443	treatment	treatment	I-NP	NN	O	2	PMOD	O
O	O	1444	1446	in	in	B-PP	IN	O	9	NMOD	O
O	O	1447	1456	semisolid	semisolid	B-NP	JJ	O	13	AMOD	O
O	O	1457	1459	or	or	I-NP	CC	O	13	AMOD	O
O	O	1460	1466	liquid	liquid	I-NP	JJ	O	14	NMOD	O
O	O	1467	1474	culture	culture	I-NP	NN	O	10	PMOD	O
O	O	1475	1479	show	show	B-VP	VBP	O	0	ROOT	O
O	O	1480	1484	that	that	B-SBAR	IN	O	15	VMOD	O
O	O	1485	1490	early	early	B-NP	JJ	O	19	NMOD	O
O	O	1491	1493	RA	RA	I-NP	NN	O	19	NMOD	O
O	O	1494	1502	addition	addition	I-NP	NN	O	20	SUB	O
O	O	1503	1505	is	be	B-VP	VBZ	O	16	SBAR	O
O	O	1506	1510	most	most	B-ADJP	RBS	O	22	AMOD	O
O	O	1511	1520	effective	effective	I-ADJP	JJ	O	20	PRD	O
O	O	1520	1521	,	,	O	,	O	15	P	O
O	O	1522	1526	thus	thus	B-ADVP	RB	O	25	VMOD	O
O	O	1527	1537	indicating	indicate	B-VP	VBG	O	15	VMOD	O
O	O	1538	1542	that	that	B-SBAR	IN	O	25	VMOD	O
O	O	1543	1548	early	early	B-NP	JJ	O	30	AMOD	O
O	O	1549	1552	but	but	I-NP	CC	O	30	AMOD	O
O	O	1553	1556	not	not	I-NP	RB	O	30	AMOD	O
O	O	1557	1561	late	late	B-NP	JJ	O	31	NMOD	O
O	O	1562	1565	HPC	HPC	I-NP	NN	B-cell_type	32	SUB	B-cell_type
O	O	1566	1569	are	be	B-VP	VBP	O	26	SBAR	O
O	O	1570	1579	sensitive	sensitive	B-ADJP	JJ	O	32	PRD	O
O	O	1580	1582	to	to	B-PP	TO	O	33	AMOD	O
O	O	1583	1586	its	its	B-NP	PRP$	O	36	NMOD	O
O	O	1587	1593	action	action	I-NP	NN	O	34	PMOD	O
O	O	1593	1594	.	.	O	.	O	15	P	O

O	O	1595	1597	We	We	B-NP	PRP	O	3	SUB	O
O	O	1598	1602	then	then	B-ADVP	RB	O	3	VMOD	O
O	O	1603	1611	analyzed	analyze	B-VP	VBD	O	37	VMOD	O
O	O	1612	1615	the	the	B-NP	DT	O	5	NMOD	O
O	O	1616	1626	expression	expression	I-NP	NN	O	3	OBJ	O
O	O	1627	1629	of	of	B-PP	IN	O	5	NMOD	O
O	O	1630	1633	the	the	B-NP	DT	O	10	NMOD	O
O	O	1634	1640	master	master	I-NP	NN	B-DNA	10	NMOD	B-DNA
T12	B-Protein	1641	1646	GATA1	GATA1	I-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	1647	1651	gene	gene	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	1651	1652	,	,	O	,	O	10	P	O
O	O	1653	1658	which	which	B-NP	WDT	O	10	NMOD	O
O	O	1659	1666	encodes	encode	B-VP	VBZ	O	12	SBAR	O
O	O	1667	1668	a	a	B-NP	DT	O	17	NMOD	O
O	O	1669	1675	finger	finger	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	1676	1689	transcription	transcription	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	1690	1696	factor	factor	I-NP	NN	I-protein	13	OBJ	I-protein
O	O	1697	1705	required	require	B-VP	VBN	O	17	NMOD	O
O	O	1706	1709	for	for	B-PP	IN	O	18	VMOD	O
O	O	1710	1716	normal	normal	B-NP	JJ	O	22	NMOD	O
O	O	1717	1726	erythroid	erythroid	I-NP	JJ	O	22	NMOD	O
O	O	1727	1738	development	development	I-NP	NN	O	19	PMOD	O
O	O	1738	1739	;	;	O	:	O	3	P	O
O	O	1740	1748	addition	addition	B-NP	NN	O	37	SUB	O
O	O	1749	1751	of	of	B-PP	IN	O	24	NMOD	O
O	O	1752	1754	RA	RA	B-NP	NN	O	25	PMOD	O
O	O	1755	1757	to	to	B-PP	TO	O	24	NMOD	O
O	O	1758	1761	HPC	HPC	B-NP	NN	B-cell_type	27	PMOD	B-cell_type
O	O	1762	1772	stimulated	stimulate	B-VP	VBN	O	28	NMOD	O
O	O	1773	1777	into	into	B-PP	IN	O	29	VMOD	O
O	O	1778	1788	unilineage	unilineage	B-NP	JJ	O	33	NMOD	O
O	O	1789	1803	erythropoietic	erythropoietic	I-NP	JJ	O	33	NMOD	O
O	O	1804	1819	differentiation	differentiation	I-NP	NN	O	30	PMOD	O
O	O	1820	1822	in	in	B-PP	IN	O	29	VMOD	O
O	O	1823	1829	liquid	liquid	B-NP	JJ	O	36	NMOD	O
O	O	1830	1837	culture	culture	I-NP	NN	O	34	PMOD	O
O	O	1838	1844	caused	cause	B-VP	VBD	O	0	ROOT	O
O	O	1845	1846	a	a	B-NP	DT	O	41	NMOD	O
O	O	1847	1856	virtually	virtually	I-NP	RB	O	40	AMOD	O
O	O	1857	1865	complete	complete	I-NP	JJ	O	41	NMOD	O
O	O	1866	1876	inhibition	inhibition	I-NP	NN	O	37	OBJ	O
O	O	1877	1879	of	of	B-PP	IN	O	41	NMOD	O
T13	B-Protein	1880	1885	GATA1	GATA1	B-NP	NN	B-RNA	45	NMOD	B-RNA
O	O	1886	1890	mRNA	mRNA	I-NP	NN	I-RNA	45	NMOD	I-RNA
O	O	1891	1900	induction	induction	I-NP	NN	O	42	PMOD	O
O	O	1900	1901	.	.	O	.	O	37	P	O

O	O	1902	1907	These	These	B-NP	DT	O	2	NMOD	O
O	O	1908	1915	results	result	I-NP	NNS	O	3	SUB	O
O	O	1916	1924	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1925	1929	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1930	1932	RA	RA	B-NP	NN	O	7	SUB	O
O	O	1933	1941	directly	directly	B-ADVP	RB	O	7	VMOD	O
O	O	1942	1950	inhibits	inhibit	B-VP	VBZ	O	4	SBAR	O
O	O	1951	1954	the	the	B-NP	DT	O	11	NMOD	O
O	O	1955	1964	erythroid	erythroid	I-NP	JJ	O	11	NMOD	O
O	O	1965	1980	differentiation	differentiation	I-NP	NN	O	11	NMOD	O
O	O	1981	1988	program	program	I-NP	NN	O	7	OBJ	O
O	O	1989	1991	at	at	B-PP	IN	O	7	VMOD	O
O	O	1992	1995	the	the	B-NP	DT	O	14	NMOD	O
O	O	1996	2001	level	level	I-NP	NN	O	12	PMOD	O
O	O	2002	2004	of	of	B-PP	IN	O	14	NMOD	O
O	O	2005	2010	early	early	B-NP	JJ	O	18	NMOD	O
O	O	2011	2016	adult	adult	I-NP	JJ	O	18	NMOD	O
O	O	2017	2020	HPC	HPC	I-NP	NN	B-cell_type	15	PMOD	B-cell_type
O	O	2020	2021	,	,	O	,	O	7	P	O
O	O	2022	2025	and	and	O	CC	O	7	VMOD	O
O	O	2026	2029	may	may	B-VP	MD	O	7	VMOD	O
O	O	2030	2034	lead	lead	I-VP	VB	O	21	VC	O
O	O	2035	2037	to	to	B-PP	TO	O	22	VMOD	O
O	O	2038	2039	a	a	B-NP	DT	O	25	NMOD	O
O	O	2040	2045	shift	shift	I-NP	NN	O	23	PMOD	O
O	O	2046	2050	from	from	B-PP	IN	O	25	NMOD	O
O	O	2051	2054	the	the	B-NP	DT	O	32	NMOD	O
O	O	2055	2064	erythroid	erythroid	I-NP	JJ	O	30	AMOD	O
O	O	2065	2067	to	to	B-PP	TO	O	30	AMOD	O
O	O	2068	2080	granulocytic	granulocytic	B-NP	JJ	O	32	NMOD	O
O	O	2081	2096	differentiation	differentiation	I-NP	NN	O	32	NMOD	O
O	O	2097	2104	pathway	pathway	I-NP	NN	O	26	PMOD	O
O	O	2104	2105	.	.	O	.	O	3	P	O

O	O	2106	2110	This	This	B-NP	DT	O	2	NMOD	O
O	O	2111	2121	phenomenon	phenomenon	I-NP	NN	O	3	SUB	O
O	O	2122	2124	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	2125	2135	correlated	correlate	I-VP	VBN	O	3	VC	O
O	O	2136	2140	with	with	B-PP	IN	O	4	VMOD	O
O	O	2141	2151	inhibition	inhibition	B-NP	NN	O	5	PMOD	O
O	O	2152	2154	of	of	B-PP	IN	O	6	NMOD	O
T14	B-Protein	2155	2160	GATA1	GATA1	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	2161	2170	induction	induction	I-NP	NN	O	7	PMOD	O
O	O	2171	2173	in	in	B-PP	IN	O	6	NMOD	O
O	O	2174	2177	the	the	B-NP	DT	O	13	NMOD	O
O	O	2178	2183	early	early	I-NP	JJ	O	13	NMOD	O
O	O	2184	2190	stages	stage	I-NP	NNS	O	10	PMOD	O
O	O	2191	2193	of	of	B-PP	IN	O	13	NMOD	O
O	O	2194	2208	erythropoietic	erythropoietic	B-NP	JJ	O	16	NMOD	O
O	O	2209	2224	differentiation	differentiation	I-NP	NN	O	14	PMOD	O
O	O	2224	2225	.	.	O	.	O	3	P	O
